Udhayakumar V, Saekhou A, Fang S, Jue D, Wohlhueter R M, Lal A A
Molecular Vaccine Section, Centers for Disease Control and Prevention, Atlanta, GA 30084, USA.
Vaccine. 1998 May-Jun;16(9-10):982-8. doi: 10.1016/s0264-410x(97)00290-9.
In this study we characterized the immunogenic properties of three different multispecies multiple antigen constructs (MACs) carrying the circumsporozoite protein (CSP) repeats of human malaria parasites, Plasmodium falciparum and P. vivax. We synthesized tetrameric MACs containing the antigenic repeats from the CSP of P. vivax-like parasite in two arms and CSP repeat sequences of either P. vivax type-1 (vivax-like/vivax type-1 MAC), P. vivax type-2 (vivax-like/vivax type-2 MAC), or P. falciparum (vivax-like/falciparum MAC) in the other two arms. Mice of four different genetic backgrounds (H-2a, H-2b, H-2d, and H-2k) were immunized with these MACs in Freund's adjuvant. All three MAC preparations were found to elicit antibodies to P. vivax-like CSP repeats in B10.BR, B10.A, and C57BL/6 mice. On the other hand, in B10.D2 mice only vivax-like/vivax type-1 MAC, but not the other two MACs induced antibodies to the P. vivax-like CSP repeats. In mice immunized with vivax-like/vivax type-1 MAC, antibodies to P. vivax type-1 CS repeat peptides were induced in B10.BR, B10.A, and C57BL/6 mice, but not in B10.D2 mice. Antibody responses to P. vivax type-2 repeats were not induced in any of the four strains of mice that were immunized with vivax-like/vivax type-2 MAC. While B10.BR, B10.A, and C57BL/6 mice produced antibodies to NANP repeats of P. falciparum CSP following immunization with vivax-like/falciparum MAC, B10.D2 mice failed to elicit antibodies to this repeat. All the sera that showed positive reactivity to peptides in enzyme-linked immunosorbent assay were found to react with sporozoites by IFA. In conclusion, these results showed that naturally immunogenic epitopes from different species of malaria parasites can be incorporated in a single vaccine construct to induce immune responses against multiple epitopes.
在本研究中,我们对三种不同的多物种多抗原构建体(MACs)的免疫原性进行了表征,这些构建体携带人类疟原虫恶性疟原虫和间日疟原虫的环子孢子蛋白(CSP)重复序列。我们合成了四聚体MACs,其两条臂含有来自间日疟原虫样寄生虫CSP的抗原重复序列,另外两条臂分别含有间日疟原虫1型(间日疟原虫样/间日疟原虫1型MAC)、间日疟原虫2型(间日疟原虫样/间日疟原虫2型MAC)或恶性疟原虫(间日疟原虫样/恶性疟原虫MAC)的CSP重复序列。用弗氏佐剂中的这些MACs免疫四种不同遗传背景(H-2a、H-2b、H-2d和H-2k)的小鼠。发现所有三种MAC制剂均可在B10.BR、B10.A和C57BL/6小鼠中引发针对间日疟原虫样CSP重复序列的抗体。另一方面,在B10.D2小鼠中,只有间日疟原虫样/间日疟原虫1型MAC可诱导针对间日疟原虫样CSP重复序列的抗体,而其他两种MAC则不能。在用间日疟原虫样/间日疟原虫1型MAC免疫的小鼠中,B10.BR、B10.A和C57BL/6小鼠可诱导针对间日疟原虫1型CS重复肽的抗体,但B10.D2小鼠中则不能。在用间日疟原虫样/间日疟原虫2型MAC免疫的四种小鼠品系中,均未诱导出针对间日疟原虫2型重复序列的抗体反应。在用间日疟原虫样/恶性疟原虫MAC免疫后,B10.BR、B10.A和C57BL/6小鼠产生了针对恶性疟原虫CSP的NANP重复序列的抗体,而B10.D2小鼠未能引发针对该重复序列的抗体。在酶联免疫吸附测定中对肽显示出阳性反应性的所有血清,通过免疫荧光法(IFA)检测发现均与子孢子发生反应。总之,这些结果表明,来自不同疟原虫物种的天然免疫原性表位可整合到单一疫苗构建体中,以诱导针对多种表位的免疫反应。